ProfileGDS4718 / 217599_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 9% 20% 10% 12% 11% 11% 10% 12% 12% 14% 23% 10% 9% 13% 16% 18% 9% 15% 18% 6% 13% 23% 12% 13% 16% 9% 10% 6% 12% 13% 34% 15% 10% 9% 17% 7% 8% 12% 30% 9% 14% 35% 11% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8025510
GSM549102patient 115, normal, homogenized [OPG study]3.768259
GSM549104patient 119, normal, homogenized [OPG study]4.1339520
GSM549108patient 138, normal, homogenized [OPG study]3.7841410
GSM549119patient 077, normal, homogenized [OPG study]3.8709812
GSM549133patient 032, cancer, homogenized [OPG study]3.7702711
GSM549139patient 042, cancer, homogenized [OPG study]3.7922811
GSM549099patient 107, normal, homogenized [OPG study]3.7938710
GSM549109patient 139, normal, homogenized [OPG study]3.8832512
GSM549110patient 046, normal, homogenized [OPG study]3.8714712
GSM549114patient 063, normal, homogenized [OPG study]3.8931214
GSM549122patient 082, normal, homogenized [OPG study]4.257523
GSM549134patient 033, cancer, homogenized [OPG study]3.7781510
GSM549136patient 036, cancer, homogenized [OPG study]3.706059
GSM549140patient 044, cancer, homogenized [OPG study]3.8530113
GSM549111patient 047, normal, homogenized [OPG study]3.9776216
GSM549113patient 057, normal, homogenized [OPG study]4.0242918
GSM549132patient 031, cancer, homogenized [OPG study]3.750539
GSM549137patient 038, cancer, homogenized [OPG study]3.937215
GSM549142patient 047, cancer, homogenized [OPG study]4.1745818
GSM549100patient 110, normal, homogenized [OPG study]3.641066
GSM549107patient 135, normal, homogenized [OPG study]3.8514913
GSM549115patient 068, normal, homogenized [OPG study]4.219423
GSM549116patient 072, normal, homogenized [OPG study]3.8541512
GSM549120patient 078, normal, homogenized [OPG study]3.8766313
GSM549131patient 030, cancer, homogenized [OPG study]3.943216
GSM549118patient 074, normal, homogenized [OPG study]3.739959
GSM549129patient 027, cancer, homogenized [OPG study]3.7921110
GSM549123patient 088, normal, homogenized [OPG study]3.657436
GSM549124patient 006, cancer, homogenized [OPG study]3.8851612
GSM549126patient 015, cancer, homogenized [OPG study]3.8557813
GSM549128patient 025, cancer, homogenized [OPG study]4.676134
GSM549103patient 117, normal, homogenized [OPG study]3.9795415
GSM549117patient 073, normal, homogenized [OPG study]3.7771310
GSM549138patient 041, cancer, homogenized [OPG study]3.742439
GSM549141patient 045, cancer, homogenized [OPG study]3.9708817
GSM549130patient 028, cancer, homogenized [OPG study]3.683057
GSM549101patient 111, normal, homogenized [OPG study]3.70648
GSM549105patient 128, normal, homogenized [OPG study]3.8590512
GSM549106patient 134, normal, homogenized [OPG study]4.4890730
GSM549112patient 048, normal, homogenized [OPG study]3.738289
GSM549125patient 011, cancer, homogenized [OPG study]3.9383914
GSM549127patient 024, cancer, homogenized [OPG study]4.7503435
GSM549135patient 035, cancer, homogenized [OPG study]3.7639611